Lifesaving Upgrades: Reviewing 40 Years of FDA Oncology Approvals

ONCOLOGY has identified FDA approvals that have affected the oncology treatment paradigm over the last 40 years.

Over the past 40 years, hundreds of drugs have been approved across a multitude of cancer types. With numbers so great, it is guaranteed that some will fall to the wayside and be forgotten while others will persist throughout decades, affecting treatment paradigms even 30 years down the line. In celebration of the journal ONCOLOGY’s 40th anniversary, it was only fitting to document prominent FDA oncology approvals, starting from 1986 and ending in 2026.